$DXCM
DEXCOM INC

2021 Q2 Form 10-Q Financial Statement

#000109355721000191 Filed on July 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $595.1M $451.8M
YoY Change 31.72% 34.3%
Cost Of Revenue $178.0M $167.7M
YoY Change 6.14% 29.1%
Gross Profit $417.1M $284.1M
YoY Change 46.81% 37.58%
Gross Profit Margin 70.09% 62.88%
Selling, General & Admin $186.5M $136.4M
YoY Change 36.73% -1.37%
% of Gross Profit 44.71% 48.01%
Research & Development $129.1M $79.90M
YoY Change 61.58% 15.8%
% of Gross Profit 30.95% 28.12%
Depreciation & Amortization $23.50M $15.30M
YoY Change 53.59% 31.9%
% of Gross Profit 5.63% 5.39%
Operating Expenses $316.1M $216.3M
YoY Change 46.14% 4.34%
Operating Profit $101.0M $67.80M
YoY Change 48.97% -8575.0%
Interest Expense $4.800M $20.30M
YoY Change -76.35% 35.33%
% of Operating Profit 4.75% 29.94%
Other Income/Expense, Net $900.0K $4.100M
YoY Change -78.05% -36.92%
Pretax Income $97.10M $46.20M
YoY Change 110.17% -596.77%
Income Tax $18.70M -$100.0K
% Of Pretax Income 19.26% -0.22%
Net Earnings $78.40M $46.30M
YoY Change 69.33% -540.95%
Net Earnings / Revenue 13.17% 10.25%
Basic Earnings Per Share $0.20 $0.49
Diluted Earnings Per Share $0.19 $0.48
COMMON SHARES
Basic Shares Outstanding 386.9M shares 93.80M shares
Diluted Shares Outstanding 427.1M shares 97.00M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.585B $2.509B
YoY Change 3.03% 82.13%
Cash & Equivalents $1.159B $530.0M
Short-Term Investments $1.426B $1.979B
Other Short-Term Assets $86.50M $62.40M
YoY Change 38.62% 98.1%
Inventory $319.3M $165.3M
Prepaid Expenses
Receivables $483.5M $296.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.474B $3.033B
YoY Change 14.55% 73.89%
LONG-TERM ASSETS
Property, Plant & Equipment $676.0M $384.3M
YoY Change 75.9% 51.78%
Goodwill $19.10M $18.70M
YoY Change 2.14% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.30M $14.20M
YoY Change 64.08% 1.43%
Total Long-Term Assets $1.030B $488.8M
YoY Change 110.64% 51.94%
TOTAL ASSETS
Total Short-Term Assets $3.474B $3.033B
Total Long-Term Assets $1.030B $488.8M
Total Assets $4.504B $3.522B
YoY Change 27.88% 70.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $165.9M $108.4M
YoY Change 53.04% 11.64%
Accrued Expenses $433.0M $290.0M
YoY Change 49.31% 56.5%
Deferred Revenue $1.800M $1.700M
YoY Change 5.88% -51.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $600.7M $400.1M
YoY Change 50.14% 38.83%
LONG-TERM LIABILITIES
Long-Term Debt $1.768B $1.673B
YoY Change 5.7% 59.41%
Other Long-Term Liabilities $87.70M $35.30M
YoY Change 148.44% 101.71%
Total Long-Term Liabilities $87.70M $35.30M
YoY Change 148.44% 101.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $600.7M $400.1M
Total Long-Term Liabilities $87.70M $35.30M
Total Liabilities $2.506B $2.168B
YoY Change 15.6% 57.37%
SHAREHOLDERS EQUITY
Retained Earnings -$98.90M -$629.5M
YoY Change -84.29% -24.54%
Common Stock $2.194B $2.080B
YoY Change 5.47% 28.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $100.0M $100.0M
YoY Change 0.0% 0.0%
Treasury Stock Shares 800.0K shares 800.0K shares
Shareholders Equity $1.755B $1.354B
YoY Change
Total Liabilities & Shareholders Equity $4.504B $3.522B
YoY Change 27.88% 70.47%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $78.40M $46.30M
YoY Change 69.33% -540.95%
Depreciation, Depletion And Amortization $23.50M $15.30M
YoY Change 53.59% 31.9%
Cash From Operating Activities $61.60M $154.1M
YoY Change -60.03% 138.91%
INVESTING ACTIVITIES
Capital Expenditures -$101.2M -$58.20M
YoY Change 73.88% 24.09%
Acquisitions
YoY Change
Other Investing Activities $464.4M -$1.057B
YoY Change -143.93% 78.41%
Cash From Investing Activities $363.2M -$1.115B
YoY Change -132.57% 74.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -400.0K 906.0M
YoY Change -100.04% -906100.0%
NET CHANGE
Cash From Operating Activities 61.60M 154.1M
Cash From Investing Activities 363.2M -1.115B
Cash From Financing Activities -400.0K 906.0M
Net Change In Cash 424.4M -55.20M
YoY Change -868.84% -90.4%
FREE CASH FLOW
Cash From Operating Activities $61.60M $154.1M
Capital Expenditures -$101.2M -$58.20M
Free Cash Flow $162.8M $212.3M
YoY Change -23.32% 90.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001093557
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dxcm Amortization Period For Incentive Compensation Costs
AmortizationPeriodForIncentiveCompensationCosts
P1Y
CY2020Q2 dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1953067 shares
CY2021Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
193600000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51222
dei Entity Registrant Name
EntityRegistrantName
DEXCOM, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0857544
dei Entity Address Address Line1
EntityAddressAddressLine1
6340 Sequence Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
428500000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
319300000 USD
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
200-0200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
dei Trading Symbol
TradingSymbol
DXCM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
96748901 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1158800000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
817600000 USD
CY2021Q2 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1426100000 USD
CY2020Q4 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1890100000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
483500000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
234700000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
86500000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53900000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
3474200000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3424800000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
676000000.0 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515300000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
94800000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
93300000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
19100000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
19300000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
216400000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
216400000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23300000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21400000 USD
CY2021Q2 us-gaap Assets
Assets
4503800000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80900000 USD
CY2020Q4 us-gaap Assets
Assets
4290500000 USD
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
482000000.0 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
481100000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98100000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
114300000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18800000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16500000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1800000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2200000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
600700000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
614100000 USD
CY2021Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1710700000 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1667200000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
107100000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101800000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87700000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Liabilities
Liabilities
2506200000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2464000000.0 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97500000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96700000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96900000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96100000 shares
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2193600000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2125300000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2800000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3200000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98900000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202100000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
100000000.0 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
100000000.0 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1997600000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1826500000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4503800000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4290500000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
595100000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1100100000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
178000000.0 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
339100000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
316300000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
417100000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
284100000 USD
us-gaap Gross Profit
GrossProfit
761000000.0 USD
us-gaap Gross Profit
GrossProfit
540600000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
129100000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
79900000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
153000000.0 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187000000.0 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
136400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
375600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
286200000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
316100000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
216300000 USD
us-gaap Operating Expenses
OperatingExpenses
614100000 USD
us-gaap Operating Expenses
OperatingExpenses
439200000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
101000000.0 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
67800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
146900000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
101400000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25200000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
20300000 USD
us-gaap Interest Expense
InterestExpense
50000000.0 USD
us-gaap Interest Expense
InterestExpense
35700000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
900000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4100000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000.0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8300000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76700000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
97900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68600000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
62900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
us-gaap Net Income Loss
NetIncomeLoss
103200000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99600000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95600000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
62900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
us-gaap Net Income Loss
NetIncomeLoss
103200000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
200000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
500000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-100000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-200000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-700000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1400000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1200000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
62800000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
102800000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67400000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1903200000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
62900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-100000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1997600000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
934500000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
289400000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
53200000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30700000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-200000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1826500000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59600000 USD
us-gaap Net Income Loss
NetIncomeLoss
103200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-400000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1997600000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882600000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
300000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6400000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
289400000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
53200000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54600000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1200000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
us-gaap Net Income Loss
NetIncomeLoss
103200000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
59600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
54600000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44700000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30300000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
100000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16000000.0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
54900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10400000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
84500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
45500000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
27100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26600000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
-1100000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
1200000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
56800000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16200000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-20800000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
3000000.0 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
15400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
156000000.0 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1171900000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1740000000.0 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1628300000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
849500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200900000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91400000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4500000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2800000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
251000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-984700000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1188800000 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
0 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6700000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8300000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
912500000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
340900000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
83600000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
818200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
446400000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1159100000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530000000.0 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1158800000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
530000000.0 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
300000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1159100000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530000000.0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1190000000.0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
43200000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
17000000.0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10400000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5300000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4600000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table>The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, transaction price, the collectibility of accounts receivable, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table>Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.
dxcm Revenue Recognition Sales Returns Coverage Period
RevenueRecognitionSalesReturnsCoveragePeriod
P30D
CY2021Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
11100000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11600000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8200000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
62900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
46300000 USD
us-gaap Net Income Loss
NetIncomeLoss
103200000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99600000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95600000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9600000 shares
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
961100000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1426100000 USD
CY2021Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
5800000 USD
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2393000000.0 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
641500000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1890100000 USD
CY2020Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
3400000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2535000000.0 USD
dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
CY2021Q2 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1426200000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
100000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
200000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1426100000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1890000000.0 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1890100000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P12Y
CY2020Q4 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P12Y
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
104600000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
69900000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13600000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14200000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
201100000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150600000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
319300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
234700000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
862800000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
669500000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
186800000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
154200000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
676000000.0 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515300000 USD
CY2021Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
165900000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
163300000 USD
CY2021Q2 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
17900000 USD
CY2020Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
15300000 USD
CY2021Q2 dxcm Pharmacy Rebates
PharmacyRebates
237400000 USD
CY2020Q4 dxcm Pharmacy Rebates
PharmacyRebates
247000000.0 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11200000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11700000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
49600000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
43800000 USD
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
482000000.0 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
481100000 USD
CY2021Q2 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
64600000 USD
CY2020Q4 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
87700000 USD
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
33500000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
26600000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98100000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
114300000 USD
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
57400000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
54000000.0 USD
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
12600000 USD
CY2020Q4 us-gaap Contractual Obligation
ContractualObligation
12600000 USD
CY2021Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
17700000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
14300000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87700000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80900000 USD
CY2021Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2200000 USD
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2400000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4600000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4700000 USD
CY2021Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-20800000 USD
CY2020Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-16500000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-41300000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-28300000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2200000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000.0 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
24100000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
20000000.0 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
48100000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
35000000.0 USD
CY2020Q2 dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1953067 shares
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5400000 USD
CY2021Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
193600000 USD
dxcm Estimated Annual Effective Income Tax Rate Percent
EstimatedAnnualEffectiveIncomeTaxRatePercent
0.271
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.054
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31600000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54600000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
210900000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
595100000 USD
CY2021Q2 dxcm Revenue Percentage
RevenuePercentage
1
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
CY2020Q2 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1100100000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
dxcm Revenue Percentage
RevenuePercentage
1
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
595100000 USD
CY2021Q2 dxcm Revenue Percentage
RevenuePercentage
1
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451800000 USD
CY2020Q2 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1100100000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
856900000 USD
dxcm Revenue Percentage
RevenuePercentage
1

Files In Submission

Name View Source Status
0001093557-21-000191-index-headers.html Edgar Link pending
0001093557-21-000191-index.html Edgar Link pending
0001093557-21-000191.txt Edgar Link pending
0001093557-21-000191-xbrl.zip Edgar Link pending
dxcm-20210630.htm Edgar Link pending
dxcm-20210630.xsd Edgar Link pending
dxcm-20210630_cal.xml Edgar Link unprocessable
dxcm-20210630_def.xml Edgar Link unprocessable
dxcm-20210630_g1.jpg Edgar Link pending
dxcm-20210630_g2.jpg Edgar Link pending
dxcm-20210630_g3.jpg Edgar Link pending
dxcm-20210630_g4.jpg Edgar Link pending
dxcm-20210630_g5.jpg Edgar Link pending
dxcm-20210630_g6.jpg Edgar Link pending
dxcm-20210630_g7.jpg Edgar Link pending
dxcm-20210630_g8.jpg Edgar Link pending
dxcm-20210630_g9.jpg Edgar Link pending
dxcm-20210630_htm.xml Edgar Link completed
dxcm-20210630_lab.xml Edgar Link unprocessable
dxcm-20210630_pre.xml Edgar Link unprocessable
dxcm6302021exhibit3101.htm Edgar Link pending
dxcm6302021exhibit3102.htm Edgar Link pending
dxcm6302021exhibit3201.htm Edgar Link pending
dxcm6302021exhibit3202.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending